Expertise in
6
conditions

Dr. Suzanne L. Gharib

Rheumatology
Stonewall Jackson Memorial Hospital Company
230 Hospital Plz, 
Weston, WV 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
Stonewall Jackson Memorial Hospital Company
230 Hospital Plz, 
Weston, WV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Suzanne Gharib is a Rheumatologist in Weston, West Virginia. Dr. Gharib is highly rated in 6 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Psoriatic Arthritis. Dr. Gharib is currently accepting new patients.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in WV
Hospital Affiliations
Charleston Area Medical Center
Mon Health Medical Center
Stonewall Jackson Memorial Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

STONEWALL JACKSON MEMORIAL HOSPITAL COMPANY
230 Hospital Plz, Weston, WV 26452
Other Locations
CHARLESTON AREA MEDICAL CENTER INC
4610 Maccorkle Ave Sw, Suite 301, South Charleston, WV 25309

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Enrollment Status: Completed
Publish Date: August 17, 2017
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

1 Total Publications

The first non-radiographic axial spondyloarthrits with COVID-19.
The first non-radiographic axial spondyloarthrits with COVID-19.
Journal: Immunity, inflammation and disease
Published: February 26, 2021
Similar Doctors
Expertise in
5
conditions
Dr. Shelly P. Kafka
Rheumatology
Expertise in
5
conditions
Dr. Shelly P. Kafka
Rheumatology
399 Emily Dr, 
Clarksburg, WV 
 (19.0 mi)
304-624-4315
Languages Spoken:
English

Shelly Kafka is a Rheumatologist in Clarksburg, West Virginia. Dr. Kafka is highly rated in 5 conditions, according to our data. Their top areas of expertise are Psoriatic Arthritis, Arthritis, Psoriasis, and Rheumatoid Arthritis (RA).

Expertise in
10
conditions
Dr. Colleen M. Watkins
Rheumatology
Expertise in
10
conditions
Dr. Colleen M. Watkins
Rheumatology

West Virginia University Medical Corporation

1 Medical Ctr Dr, 
Morgantown, WV 
 (50.7 mi)
304-598-4865
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Colleen Watkins is a Rheumatologist in Morgantown, West Virginia. Dr. Watkins is highly rated in 10 conditions, according to our data. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Melorheostosis, Vitamin D Deficiency, and Vertebroplasty. Dr. Watkins is currently accepting new patients.

Expertise in
20
conditions
Dr. Alicia J. Zbehlik
Rheumatology
Expertise in
20
conditions
Dr. Alicia J. Zbehlik
Rheumatology

West Virginia University Medical Corporation

600 Suncrest Town Centre Dr, 
Morgantown, WV 
 (51.1 mi)
304-598-4478
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alicia Zbehlik is a Rheumatologist in Morgantown, West Virginia. Dr. Zbehlik is highly rated in 20 conditions, according to our data. Her top areas of expertise are Juvenile Temporal Arteritis, Giant Cell Arteritis (GCA), Necrotizing Vasculitis, and Temporal Arteritis. Dr. Zbehlik is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gharib's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile